Literature DB >> 8474179

The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro.

R E Bellas1, N Hopkins, Y Li.   

Abstract

We demonstrate here that the nuclear factor-kappa B (NF-kappa B) binding site in the simian immunodeficiency virus (SIVmac) long terminal repeat is essential for efficient virus replication in primary alveolar macrophages but dispensable for efficient replication in primary T cells. Mutation of the NF-kappa B site does not seriously impair replication of a T-cell-tropic SIVmac239 or a macrophagetropic SIVmacEm* in peripheral blood lymphocytes or established CD4+ cell lines; however, mutation of the NF-kappa B site prevents efficient SIVmacEm* replication in primary alveolar macrophages. These data suggest that efficient replication in primary macrophages requires both envelope and long terminal repeat determinants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474179      PMCID: PMC237617     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay.

Authors:  B R Franza; S F Josephs; M Z Gilman; W Ryan; B Clarkson
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

Review 2.  Biology and pathogenesis of lentiviruses.

Authors:  O Narayan; J E Clements
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

3.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 4.  Pathogenesis of lentivirus infections.

Authors:  A T Haase
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

5.  The HIV 'A' (sor) gene product is essential for virus infectivity.

Authors:  K Strebel; D Daugherty; K Clouse; D Cohen; T Folks; M A Martin
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

6.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

7.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

8.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

10.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

View more
  10 in total

1.  Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.

Authors:  S R Lewin; P Lambert; N J Deacon; J Mills; S M Crowe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus.

Authors:  M T Flaherty; D A Hauer; J L Mankowski; M C Zink; J E Clements
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Authors:  J M Jacqué; B Fernández; F Arenzana-Seisdedos; D Thomas; F Baleux; J L Virelizier; F Bachelerie
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.

Authors:  S C Dollard; S Gummuluru; S Tsang; P N Fultz; S Dewhurst
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.

Authors:  Y J Chan; C J Chiou; Q Huang; G S Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 7.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements.

Authors:  P O Ilyinskii; R C Desrosiers
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.

Authors:  G Franzoso; P Biswas; G Poli; L M Carlson; K D Brown; M Tomita-Yamaguchi; A S Fauci; U K Siebenlist
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

Authors:  Suha Saleh; Hao K Lu; Vanessa Evans; David Harisson; Jingling Zhou; Anthony Jaworowski; Georgina Sallmann; Karey Y Cheong; Talia M Mota; Surekha Tennakoon; Thomas A Angelovich; Jenny Anderson; Andrew Harman; Anthony Cunningham; Lachlan Gray; Melissa Churchill; Johnson Mak; Heidi Drummer; Dimitrios N Vatakis; Sharon R Lewin; Paul U Cameron
Journal:  Retrovirology       Date:  2016-07-26       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.